Levi & korsinsky, llp notifies shareholders of adamas pharmaceuticals, inc. (adms) an upcoming claims deadline in a class action settlement

New york, ny / accesswire / may 16, 2024 / levi & korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against adamas pharmaceuticals, inc. (nasdaq:adms). the settlement provides for a fund of $4,650,000 to benefit class members.
ADMS Ratings Summary
ADMS Quant Ranking